Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
- PMID: 18184370
- DOI: 10.1111/j.1601-183X.2007.00376.x
Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
Abstract
Phosphorylation is the most common post-translational modification of cellular proteins, essential for most physiological functions. Deregulation of phosphorylation has been invoked in disease mechanisms, and the case of Alzheimer's disease (AD) is no exception: both in the amyloid pathology and in the tauopathy are kinases deeply implicated. The glycogen synthase kinase-3 (GSK-3) isozymes participate in diverse cellular processes and important signalling pathways and have been implicitly linked to diverse medical problems, i.e. from diabetes and cancer to mood disorders and schizophrenia, and in the neurodegeneration of AD. Here, we review specific aspects of GSK-3 isozymes in the framework of recent data that we obtained in novel transgenic mouse models that robustly recapitulate the pathology and mechanistical problems of AD.
Similar articles
-
Chronic lithium treatment decreases tau lesions by promoting ubiquitination in a mouse model of tauopathies.Acta Neuropathol. 2005 Dec;110(6):547-56. doi: 10.1007/s00401-005-1087-4. Epub 2005 Oct 14. Acta Neuropathol. 2005. PMID: 16228182
-
Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.Expert Rev Neurother. 2010 May;10(5):703-10. doi: 10.1586/ern.10.40. Expert Rev Neurother. 2010. PMID: 20420491
-
GSK3: a possible link between beta amyloid peptide and tau protein.Exp Neurol. 2010 Jun;223(2):322-5. doi: 10.1016/j.expneurol.2009.09.011. Epub 2009 Sep 24. Exp Neurol. 2010. PMID: 19782073 Review.
-
Tau phosphorylation and aggregation in Alzheimer's disease pathology.FEBS Lett. 2006 May 22;580(12):2922-7. doi: 10.1016/j.febslet.2006.02.067. Epub 2006 Mar 3. FEBS Lett. 2006. PMID: 16529745 Review.
-
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21. Exp Neurol. 2008. PMID: 18490011
Cited by
-
Beyond Amyloid: A Machine Learning-Driven Approach Reveals Properties of Potent GSK-3β Inhibitors Targeting Neurofibrillary Tangles.Int J Mol Sci. 2024 Feb 24;25(5):2646. doi: 10.3390/ijms25052646. Int J Mol Sci. 2024. PMID: 38473895 Free PMC article.
-
Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism.Mol Neurobiol. 2024 Jun;61(6):3121-3143. doi: 10.1007/s12035-023-03763-4. Epub 2023 Nov 17. Mol Neurobiol. 2024. PMID: 37976025
-
Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice.Int J Mol Sci. 2022 Mar 2;23(5):2757. doi: 10.3390/ijms23052757. Int J Mol Sci. 2022. PMID: 35269905 Free PMC article.
-
Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease.Int J Mol Sci. 2020 Dec 7;21(23):9318. doi: 10.3390/ijms21239318. Int J Mol Sci. 2020. PMID: 33297460 Free PMC article. Review.
-
Protein phosphatase 1 alpha enhances glucocorticoid receptor activity by a mechanism involving phosphorylation of serine-211.Mol Cell Endocrinol. 2020 Dec 1;518:110873. doi: 10.1016/j.mce.2020.110873. Epub 2020 Jun 22. Mol Cell Endocrinol. 2020. PMID: 32585168 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical